人工股関節置換術の世界市場：2024-2031年

人工股関節置換術の世界市場規模、シェア、動向：製品タイプ別（人工股関節全置換術、人工股関節部分置換術、人工股関節表面置換術）、エンドユーザー別（病院、整形外科専門クリニック、外来手術センター（ASCs））予測期間（2024年～2031年）分析レポート

人工股関節置換術の世界市場は、予測期間中に3.9%という緩やかなCAGRで成長すると予測されます。人工股関節置換術の増加が世界市場の需要を生み出しています。医療研究・品質調査機構によると、米国では毎年45万件以上の人工股関節置換術が行われています。骨粗鬆症と関節炎の世界の有病率の上昇が、市場の需要をさらに後押ししています。国際骨粗鬆症財団の推計によると、欧州、米国、日本で7,500万人が骨粗鬆症に罹患しています。アジアでは、骨粗鬆症の診断と治療が非常に不十分で、すでに骨折しているような最もリスクの高い患者でさえ治療を受けていません。人工関節置換術につながる交通事故事例の増加が、市場の成長をさらに後押ししています。

AR/VR統合とロボット支援手術の進行中の動向は、世界市場の成長に有利な機会を提供すると予想されます。Oyster & Pearls Hospitals, Jehangir Specialty Hospitalは、ARガイド下ロボット関節置換手術を導入しました。この統合により、外科医は重要な情報をリアルタイムで視野に直接重ね合わせることができるようになりました。これには、患者の股関節の解剖学的構造の3Dモデルや、インプラントの位置に関するライブデータが含まれます。

米国FDAの承認は、人工股関節置換術用機器の商業的導入に必須です。2022年1月、米国FDAは股関節全置換術用医療機器Synovo Total Hip Systemを使用しないようヘルスケアプロバイダーに警告しました。FDAはSynovoに警告書を出し、FDAの承認なしに器具が改良されていたとして、全置換股関節システムの製造中止を命じました。

セグメント別の見通し

股関節全置換術は世界の人工股関節置換術市場で大きなシェアを占める

米国整形外科学会によると、人工股関節全置換術（股関節全置換術とも呼ばれる）では、損傷した骨と軟骨を取り除き、人工関節のコンポーネントと置き換えます。人工股関節置換術は、関節の損傷が修復不可能で、関節の機能を妨げている場合に選択されます。変形性股関節症やその他の事故による股関節損傷は、人工股関節全置換術の需要を生み出す主な要因です。人工股関節全置換術の需要に対応するための新製品の発売が、この市場セグメントの成長にさらに貢献しています。例えば、2021年2月、OrthoGrid Systems, Inc.は、股関節前方直接全置換術のための歪み補正、インプラント診断、術中アライメント技術であるOrthoGrid Hipを発売しました。

地域別展望

人工股関節置換術の世界市場は、北米（米国とカナダ）、欧州（イタリア、スペイン、ドイツ、フランス、その他）、アジア太平洋（インド、中国、日本、韓国、その他）、その他のアジア地域（中東・アフリカ、南米）など、地域別にさらに細分化されています。アジア太平洋は、世界市場においてかなりの成長が見込まれています。医療費の増加、事故事例の増加、有利な償還政策、新興国における医療ツーリズムの拡大が、この地域の市場成長を促進する主な要因です。

北米が世界市場で大きなシェアを占める

同地域の市場シェアを牽引しているのは、変形性股関節症の有病率の高さと人工股関節置換術の需要の高さです。主要製品の発売と主要市場プレーヤーの集中が、地域市場の成長をさらに後押ししています。例えば、2021年8月、Zimmer Biomet Holdings, Inc.は、ロボット支援直接前方股関節全置換術用ROSA Hip Systemの米国FDA 510（k）認可を取得しました。米国における股関節全置換術の費用は大きく異なり、価格は2万米ドルから4万2,000米ドルです。この手術費用の高さは、市場の成長を抑制する可能性があります。しかし、ほとんどの医療保険制度が股関節全置換術をカバーしています。したがって、これらの手術に対する需要の高まりと有利な償還政策は、市場成長に有利な機会を提供すると予想されます。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• Corin Group
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Smith & Nephew Plc
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Stryker Corp.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Zimmer Biomet Holdings Inc.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• 人工股関節置換術の世界市場：製品タイプ別
  • 人工股関節置換術
  • 股関節部分置換術
  • 股関節表面置換術
• 人工股関節置換術の世界市場：エンドユーザー別
  • 病院
  • 整形外科専門クリニック
  • 外来手術センター（ASC）

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
• その他アジア太平洋
• 世界のその他の地域

第6章 企業プロファイル

• AAP Implantate AG
• Aesculap, Inc.（B. Braun Co.）
• Allegra Orthopaedics Ltd.
• Alphatec Spine, Inc.
• B.Braun
• Conmed Corp.
• DJO, LLC
• Enovis
• Exactech, Inc.
• Integra LifeSciences Corp.
• Johnson & Johnson（DePuy Synthes Companies）
• Limacorporate S.p.A
• Medtronic plc
• NuVasive, Inc.
• Orthofix Medical Inc.
• SurgTech Inc.
• TriMed Inc.
• Wright Medical Group N.V.

LIST OF TABLES

• 1.GLOBAL HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2023-2031 ($ MILLION)
• 2.GLOBAL TOTAL HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 3.GLOBAL PARTIAL HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 4.GLOBAL HIP RESURFACING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 5.GLOBAL HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
• 6.GLOBAL HIP REPLACEMENT IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 7.GLOBAL HIP REPLACEMENT IN SPECIALIZED ORTHOPEDIC CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 8.GLOBAL HIP REPLACEMENT IN AMBULATORY SURGICAL CENTERS (ASCS) MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 9.GLOBAL HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 10.NORTH AMERICAN HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 11.NORTH AMERICAN HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2023-2031 ($ MILLION)
• 12.NORTH AMERICAN HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
• 13.EUROPEAN HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 14. EUROPEAN HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2023-2031 ($ MILLION)
• 15.EUROPEAN HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
• 16.ASIA-PACIFIC HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 17.ASIA-PACIFIC HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2023-2031 ($ MILLION)
• 18.ASIA-PACIFIC HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
• 19.REST OF THE WORLD HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 20.REST OF THE WORLD HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2023-2031 ($ MILLION)
• 21.REST OF THE WORLD HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)

LIST OF FIGURES

• 1.GLOBAL HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2023 VS 2031 (%)
• 2.GLOBAL TOTAL HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
• 3.GLOBAL PARTIAL HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
• 4.GLOBAL HIP RESURFACING MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
• 5.GLOBAL HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2023 VS 2031 (%)
• 6.GLOBAL HIP REPLACEMENT IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
• 7.GLOBAL HIP REPLACEMENT IN SPECIALIZED ORTHOPEDIC CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
• 8.GLOBAL HIP REPLACEMENT IN AMBULATORY SURGICAL CENTERS (ASCS) MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
• 9.GLOBAL HIP REPLACEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
• 10.US HIP REPLACEMENT MARKET SIZE, 2023-2031 ($ MILLION)
• 11.CANADA HIP REPLACEMENT MARKET SIZE, 2023-2031 ($ MILLION)
• 12.UK HIP REPLACEMENT MARKET SIZE, 2023-2031 ($ MILLION)
• 13.FRANCE HIP REPLACEMENT MARKET SIZE, 2023-2031 ($ MILLION)
• 14.GERMANY HIP REPLACEMENT MARKET SIZE, 2023-2031 ($ MILLION)
• 15.ITALY HIP REPLACEMENT MARKET SIZE, 2023-2031 ($ MILLION)
• 16.SPAIN HIP REPLACEMENT MARKET SIZE, 2023-2031 ($ MILLION)
• 17.REST OF EUROPE HIP REPLACEMENT MARKET SIZE, 2023-2031 ($ MILLION)
• 18.INDIA HIP REPLACEMENT MARKET SIZE, 2023-2031 ($ MILLION)
• 19.CHINA HIP REPLACEMENT MARKET SIZE, 2023-2031 ($ MILLION)
• 20.JAPAN HIP REPLACEMENT MARKET SIZE, 2023-2031 ($ MILLION)
• 21.SOUTH KOREA HIP REPLACEMENT MARKET SIZE, 2023-2031 ($ MILLION)
• 22.REST OF ASIA-PACIFIC HIP REPLACEMENT MARKET SIZE, 2023-2031 ($ MILLION)
• 23.LATIN AMERICA HIP REPLACEMENT MARKET SIZE, 2023-2031 ($ MILLION)
• 24.THE MIDDLE EAST & AFRICA HIP REPLACEMENT MARKET SIZE, 2023-2031 ($ MILLION)

Global Hip Replacement Market Size, Share & Trends Analysis Report by Product Type (Total Hip Replacement, Partial Hip Replacement, and Hip Resurfacing), and by End-User (Hospitals, Specialized Orthopedic Clinics, and Ambulatory Surgical Centers (ASCs)) Forecast Period (2024-2031)

The global hip replacement market is anticipated to grow at a moderate CAGR of 3.9% during the forecast period. The rising hip replacement procedures have created demand for the global market. According to the Agency for Healthcare Research and Quality, more than 450,000 total hip replacements are performed each year in the US. The rising prevalence of osteoporosis and, arthritis globally is further aiding the market demand. According to the International Osteoporosis Foundation estimation, 75 million people in Europe, the US, and Japan are affected by osteoporosis. In Asia, osteoporosis is greatly underdiagnosed and under-treated, even in the most high-risk patients who have already fractured. The increasing number of road accident cases that led to joint replacement surgeries is further aiding the market growth.

The ongoing trend of AR/VR integration and robotic-assisted surgery is anticipated to offer lucrative opportunities for the growth of the global market. Oyster & Pearls Hospitals, Jehangir Specialty Hospital has introduced AR-guided robotic joint replacement surgery. This integration has enabled surgeons to overlay vital information directly onto their field of vision in real time. This includes 3D models of the patient's hip anatomy and live data about implant positioning.

The US FDA approval is mandatory for the commercial introduction of hip replacement surgical devices. In January 2022, the US FDA warned healthcare providers not to use the Synovo Total Hip System, a medical device for total hip replacements. The agency issued a warning letter to Synovo ordering the manufacturer to stop manufacturing the Total Hip System because the device had been modified without FDA approval.

Segmental Outlook

The global hip replacement market is segmented based on product type, and end-user. Based on product type, the market is segmented into total hip replacement, partial hip replacement, and hip resurfacing. Based on end-users, the market is segmented into hospitals, specialized orthopedic clinics, and ASCs.

Total Hip Replacement to Hold Considerable Share in the Global Hip Replacement Market

According to the American Academy of Orthopaedic Surgeons, in a total hip replacement (also called total hip arthroplasty), the damaged bone and cartilage are removed and replaced with prosthetic components. Hip replacement is the option when joint damage is irreparable and hinders the joint's function. Osteoarthritis and other hip injuries caused due to accident cases are key factors creating demand for total hip replacement surgeries. New product launches to cater to the demand for total hip replacement are further contributing to the growth of this market segment. For instance, in February 2021, OrthoGrid Systems, Inc. launched the OrthoGrid Hip, which is a distortion-correcting, implant-agnostic, intraoperative-alignment technology for direct anterior hip total hip arthroplasty.

Regional Outlook

The global hip replacement market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Asia-Pacific is anticipated to exhibit considerable growth in the global market. The growing medical expenditure, rising accident cases, favorable reimbursement policies, and growing medical tourism in emerging economies a key factors driving the regional market growth.

North America Held Considerable Share in the Global Market

The regional market share is driven by the high prevalence of osteoarthritis and the high demand for hip replacement surgeries. Key product launches and a high concentration of major market players are further aiding the regional market growth. For instance, in August 2021, Zimmer Biomet Holdings, Inc. received US FDA 510(k) clearance of the ROSA Hip System for robotically-assisted direct anterior total hip replacement. cost of total hip replacement surgery in the US varies greatly, with prices between $20,000 and $42,000. The high cost of this surgery can restrain its market growth. However, most health plans cover total hip replacement surgery. Therefore, the growing demand for these procedures along with favorable reimbursement policies is anticipated to offer lucrative opportunities to the market growth.

Market Players Outlook

The major companies serving the global hip replacement market include SurgTech Inc., Corin Group, Smith & Nephew Plc, Zimmer Biomet Holdings Inc., and Stryker Corp. among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and advancement in their product offerings to stay competitive in the market. For instance, in December 2023, Stryker Corp. executed a binding offer to Menix to acquire SERF SAS, a France-based joint replacement company. This acquisition would complement Stryker's existing presence in France and across Europe as well as its global joint replacement portfolio, allowing Stryker to serve a wider range of patients.

The Report Covers:

• Market value data analysis of 2023 and forecast to 2031.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global hip replacement market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1.Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1.Research Methods and Tools
• 1.2.Market Breakdown
  • 1.2.1.By Segments
  • 1.2.2.By Region

2.Market Overview and Insights

• 2.1.Scope of the Report
• 2.2.Analyst Insight & Current Market Trends
  • 2.2.1.Key Findings
  • 2.2.2.Recommendations
  • 2.2.3.Conclusion

3.Competitive Landscape

• 3.1.Key Company Analysis
• 3.2.Corin Group
  • 3.2.1.Overview
  • 3.2.2.Financial Analysis
  • 3.2.3.SWOT Analysis
  • 3.2.4.Recent Developments
• 3.3.Smith & Nephew Plc
  • 3.3.1.Overview
  • 3.3.2.Financial Analysis
  • 3.3.3.SWOT Analysis
  • 3.3.4.Recent Developments
• 3.4.Stryker Corp.
  • 3.4.1.Overview
  • 3.4.2.Financial Analysis
  • 3.4.3.SWOT Analysis
  • 3.4.4.Recent Developments
• 3.5.Zimmer Biomet Holdings Inc.
  • 3.5.1.Overview
  • 3.5.2.Financial Analysis
  • 3.5.3.SWOT Analysis
  • 3.5.4.Recent Developments
• 3.6.Key Strategy Analysis

4.Market Segmentation

• 4.1.Global Hip Replacement Market by Product Type
  • 4.1.1.Total Hip Replacement
  • 4.1.2.Partial Hip Replacement
  • 4.1.3.Hip Resurfacing
• 4.2.Global Hip Replacement Market by End-User
  • 4.2.1.Hospitals
  • 4.2.2.Specialized Orthopedic Clinics
  • 4.2.3.Ambulatory Surgical Centers (ASCs)

5.Regional Analysis

• 5.1.North America
  • 5.1.1.United States
  • 5.1.2.Canada
• 5.2.Europe
  • 5.2.1.UK
  • 5.2.2.Germany
  • 5.2.3.Italy
  • 5.2.4.Spain
  • 5.2.5.France
  • 5.2.6.Rest of Europe
• 5.3.Asia-Pacific
  • 5.3.1.China
  • 5.3.2.India
  • 5.3.3.Japan
  • 5.3.4.South Korea
• 5.4.Rest of Asia-Pacific
• 5.5.Rest of the World

6.Company Profiles

• 6.1.AAP Implantate AG
• 6.2.Aesculap, Inc. (B. Braun Co.)
• 6.3.Allegra Orthopaedics Ltd.
• 6.4.Alphatec Spine, Inc.
• 6.5.B.Braun
• 6.6.Conmed Corp.
• 6.7.DJO, LLC
• 6.8.Enovis
• 6.9.Exactech, Inc.
• 6.10.Integra LifeSciences Corp.
• 6.11.Johnson & Johnson (DePuy Synthes Companies)
• 6.12.Limacorporate S.p.A
• 6.13.Medtronic plc
• 6.14.NuVasive, Inc.
• 6.15.Orthofix Medical Inc.
• 6.16.SurgTech Inc.
• 6.17.TriMed Inc.
• 6.18.Wright Medical Group N.V.